Abstract
Primary tumor resection (PTR) in metastatic breast cancer is not a standard treatment modality, and its impact on survival is conflicting. The primary objective of this study was to analyze impact of PTR on survival in metastatic patients with breast cancer. A retrospective study of metastatic patients with breast cancer was conducted using the 1988-2011 Surveillance, Epidemiology, and End Results (SEER) data base. Cox proportional hazards regression models were used to evaluate the relationship between PTR and survival and to adjust for the heterogeneity between the groups, and a propensity score-matched analysis was also performed. A total of 29 916 patients with metastatic breast cancer were included in the study, and 15 129 (51%) of patients underwent primary tumor resection, and 14 787 (49%) patients did not undergo surgery. Overall, decreasing trend in PTR for metastatic breast cancer in last decades was noted. Primary tumor resection was associated with a longer median OS (34 vs 18 months). In a propensity score-matched analysis, prognosis was also more favorable in the resected group (P = .0017). Primary tumor resection in metastatic breast cancer was associated with survival improvement, and the improvement persisted i...Continue Reading
References
Oct 31, 2002·Surgery·Seema A KhanMonica Morrow
Mar 18, 2004·Cancer Research·Erika A DannaSuzanne Ostrand-Rosenberg
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fabrice AndreMarc Spielmann
Apr 15, 2006·Annals of Surgical Oncology·Gildy V BabieraGabriel N Hortobagyi
May 17, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elisabetta RapitiChristine Bouchardy
May 25, 2007·Annals of Surgical Oncology·Jennifer GnerlichJulie A Margenthaler
Apr 29, 2008·Annals of Surgery·D Kay BlanchardRichard M Elledge
Aug 30, 2008·Annals of Surgical Oncology·B CadyB L Smith
Nov 26, 2008·Breast Disease·Larry Norton
Jun 10, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D Ali, R Le Scodan
Jun 30, 2011·Breast Cancer Research and Treatment·Laura DominiciMehra Golshan
Oct 29, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Z M RashaanG J Liefers
May 8, 2013·Annals of Surgical Oncology·Seema A Khan
Oct 12, 2013·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 11, 2014·Cancer·Catherine L AkayGildy V Babiera
May 27, 2014·American Society of Clinical Oncology Educational Book·Linda R DuskaDon S Dizon
Sep 14, 2015·The Lancet Oncology·Rajendra BadweSudeep Gupta
Dec 3, 2015·JAMA Surgery·Alexandra ThomasMary C Schroeder
Mar 5, 2016·Annals of Surgery·Rene WarschkowMarkus Joerger
Jun 9, 2016·Breast Cancer Research and Treatment·Antonio Di MeglioInes Vaz-Luis
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Citations
Oct 6, 2018·The Breast Journal·Mahvish MuzaffarNasreen A Vohra
Oct 9, 2018·The Breast Journal·Zeki Gokhan Surmeli
Feb 15, 2019·The Breast Journal·Nita S NairRajendra A Badwe
Mar 29, 2020·PeerJ·Yuxiang LinChuangui Song
Feb 7, 2020·Current Oncology Reports·Igor Makhlin, Kevin Fox
Nov 24, 2020·Critical Reviews in Oncology/hematology·E Pons-TostivintC Vaysse
Nov 19, 2020·Journal of Personalized Medicine·Maria Ida AmabileAlessio Molfino
Feb 4, 2021·Annals of Surgical Oncology·Atilla SoranEfe Sezgin
Jul 24, 2021·Indian Journal of Surgical Oncology·Gaurav PatelPrakash Patil
Aug 24, 2021·Head & Neck·Shi-Min ZhuangTian-Run Liu
Nov 23, 2021·Frontiers in Surgery·Kunlong LiGuanqun Ge